
Chief executive of Dendreon John Johnson is to step down in the summer amid falling sales of the company’s key …
Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia

